David Southwell: CEO of Volastra Therapeutics

Feb. 28, 2026 Season: 8 Duration: 31:26 Episode: 88
Portrait of David Southwell

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.

Atrium Banner
Alexion Pharmaceuticals

Atrium Corporate Intranet
Computer chip/molecular design concept animation.
TandemAI

Discovery as a Service
"Renews my spirit every week" quote banner
WSHU Public Radio

Lifeline to the World